Allergan Aesthetics, an AbbVie (ABBV) company, announced the launch of the Skin Quality Index. “The framework is supported by the most comprehensive global research to date published in Dermatologic Surgery, which identified inconsistencies in terminology used by patients and providers, and highlighted the need for clearer, more consistent language during aesthetic consultations,” the company said.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie Advances Risankizumab Dosing Study, Signaling Ongoing Immunology Investment
- AbbVie Stock (ABBV) Trades at a Discount Despite Fast Growth — a Bullish Case
- Neutral Hold on AbbVie as Early Cardiometabolic Pipeline Shows Promise but Trails Leading Competitors
- AbbVie reports ‘positive’ results from Phase 1 study of ABBV-295
- Exxon, AbbVie, Chevron, Home Depot, Rivian Insider Shock